Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

President Obama Releases Statement, Video Urging U.S. Residents To Get Tested For HIV
President Obama on Saturday released a statement marking National HIV Testing Day that urged U.S. residents to get tested for HIV and work toward reducing the spread of the virus, Bloomberg/Arizona Daily Star reports (Bloomberg/Arizona Daily Star, 6/28). Obama said in the statement, "Each of us must take responsibility for reducing our risk of acquiring or transmitting HIV and for supporting affected individuals and communities. This means getting tested for HIV and working to end the stigma and discrimination people living with HIV face." The White House also released a video message with Obama"s statement (White House release, 6/27).
generic viagra online
Over 50 Pharmacists Trained Up For NPA's Seasonal Flu Vaccination Service
Over 50 pharmacists have been trained to provide seasonal flu vaccinations under a private Patient Group Direction that the NPA is facilitating. Training days were conducted in London and Birmingham with further training days scheduled at the start of September 2009 in Newport, Durham, St Albans and Haydock.
News of the day
InDex Pharmaceuticals AB Engages PharmaVentures To Facilitate The Licensing Of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
PharmaVentures Ltd, announced that it has been engaged by InDex Pharmaceuticals AB to advise and assist in out-licensing its first in class therapeutic, Kappaproct (DIMS 0150), for the treatment of steroid resistant / dependent Inflammatory Bowel Disease (IBD). The engagement will utilise PharmaVentures" transactions experience in the healthcare and investment business sectors.
Endocrinology

Quantum Immunologics Achieves Major Funding In Support Of Ongoing FDA Trials

Quantum Immunologics, Inc. (QI), a Tampa, Florida company focusing on the research and development of cancer immunotherapies, is pleased to announce that it is receiving equity funding from Mentor Capital, Inc. (PINKSHEETS: MNTR) to support its FDA authorized Phase I/II trials on metastatic breast cancer, which are now underway (NCT00879489). QI"s clinical trial is designed around the use of QI"s proprietary dendritic cell therapy, which employs oncofetal antigen ("OFA") to recruit the patient"s own immune system to target and attack the cancer cells with the intent to improve patient survivability and quality of life. Each patient will receive three monthly injections of the patient"s own dendritic cells that have been sensitized to OFA. It is anticipated that once the sensitized cells are injected back into the patient, the patient"s T-cells will locate the OFA found on the patient"s cancer cells, thereby generating an immune response with the goal of killing the cancer cells and preventing further spread of the disease. In addition to providing $2.2 Million in funding to help support the FDA trials through approximately February 2010, Mentor Capital has agreed to assist QI in funding future strategic stock or cash acquisitions. Mentor will also stand by as a preferred funding for QI during later stage or additional trials. Comprehensive information on Mentor Capital, including capital structure detail, can be found at: www.MentorCapital.com. Quantum Immunologics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009